Skip to main content

HEALTHPEAK PROP. Inc. Value Stock - Dividend - Research Selection

Hcp

ISIN: US42250P1030 , WKN: A2N5NP

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

HCP, Inc. is a fully integrated real estate investment trust (REIT) that invests primarily in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index. For more information regarding HCP, visit www.hcpi.com.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


8 Dividend S&P 500 Stocks Yield Enough To Still Be Worthwhile

2026-05-28
It's getting tougher to find S&P 500 dividend stocks that make any sense anymore. Thanks to skyrocketing stock prices, the S&P 500's yield is now less than 1%. Meanwhile, the yield on Vanguard Total Bond Market ETF is up to nearly 4%.

Scotiabank Maintains Sector Perform on Healthpeak Properties, Raises Price Target to $21

2026-05-27
Scotiabank analyst Nicholas Yulico maintains Healthpeak Properties (NYSE:DOC) with a Sector Perform and raises the price target from $19 to $21.

Healthpeak Properties Gains 22.7% Year to Date: Will the Trend Last?

2026-05-26
DOC gains 22.7% year-to-date, driven by leasing momentum, rising occupancy and Janus Living growth.

SPHD’s High Dividend Low Volatility Promise Has Returned Just 6 Percent Annualized While the S&P 500 Doubled It

2026-05-26
The Invesco S&P 500 High Dividend Low Volatility ETF (NYSEARCA:SPHD) sells the most appealing pitch in income investing: take the highest yielders in the S&P 500, filter for the calmest fifty, collect monthly checks. Over the last five years that pitch delivered 36% in total, or roughly 6% annualized. The SPDR S&P 500 ETF Trust ... SPHD’s High Dividend Low Volatility Promise Has Returned Just 6 Percent Annualized While the S&P 500 Doubled It

Morgan Stanley Maintains Overweight on Healthpeak Properties, Raises Price Target to $20

2026-05-22
Morgan Stanley analyst Richard Hill maintains Healthpeak Properties (NYSE:DOC) with a Overweight and raises the price target from $18 to $20.

A Look At Healthpeak Properties (DOC) Valuation After Strong Recent Share Price Momentum

2026-05-20
Healthpeak Properties (DOC) has been drawing attention after recent share price moves, with the stock showing double digit total returns over the past year and over the past 3 months, alongside mixed annual revenue and net income trends. See our latest analysis for Healthpeak Properties. The current US$19.66 share price sits against a backdrop of strong recent momentum, with a 30 day share price return of 14.97% and a year to date gain of 21.36%, while the 5 year total shareholder return...

Verizon and 4 Other Stocks With 5% Yields—and Market-Beating Returns

2026-05-18
It isn’t easy to find attractive dividend yields right now, and it’s even harder to find high-yielding stocks that don’t look like yield traps. The S&P 500 is up a solid 8.7%, but that growth, along with the popularity of dividend-averse tech stocks, has pushed the yield on the close to 1%—near record lows.

Baird Raises its Price Target on Healthpeak Properties (DOC)

2026-05-18
Healthpeak Properties, Inc. (NYSE:DOC) is one of the 10 Fastest Growing S&P 500 Stocks to Buy Now. On May 13, 2026, Baird analyst Wesley Golladay raised the firm’s price target on Healthpeak Properties, Inc. (NYSE:DOC) to $21 from $19 while maintaining an Outperform rating on the shares. The firm updated its model following the company’s […]

Buried Treasures:  5 Undervalued High-Yield REITs With Strong Balance Sheets

2026-05-18
REITs present attractive value, thanks in part to a shortage of new supply and relative immunity to AI disruption, and are outperforming the S&P YTD. Read our list of investment picks here.

RBC Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $21

2026-05-14
RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $20 to $21.